Supplementary Table S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

<p>Supplemental Table S11. Quantification of each protein-specific band normalized to vinculin (C4-2b–derived models, Fig. 4E).</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Chuandong Geng (17315310) (author)
Beste egile batzuk:	Man-Chao Zhang (17315313) (author), Ganiraju C. Manyam (17315316) (author), Jody V. Vykoukal (17315319) (author), Johannes F. Fahrmann (15052230) (author), Shan Peng (17315322) (author), Cheng Wu (17315325) (author), Sanghee Park (17315328) (author), Shakuntala Kondraganti (17315331) (author), Daoqi Wang (17315334) (author), Brian D. Robinson (16755326) (author), Massimo Loda (14958363) (author), Christopher E. Barbieri (15012150) (author), Timothy A. Yap (15028749) (author), Paul G. Corn (17315337) (author), Samir Hanash (17314360) (author), Bradley M. Broom (15022580) (author), Patrick G. Pilié (15119957) (author), Timothy C. Thompson (17315340) (author)
Argitaratua:	2025
Gaiak:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling DNA Damage and Repair Drug Mechanisms Genitourinary Cancers Prostate cancer Small Molecule Agents
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak